According to the company, a $68 million Series D financing is co-led by Arboretum Ventures and Johnson & Johnson Innovation – ...

The effort represents a consortium of researchers from Penn Medicine, Penn Engineering, the University of Michigan Kellogg ...

Coordinated by the International Agency for the Prevention of Blindness under the Love Your Eyes campaign banner, World Sight ...

A team of researchers at Arizona State University has developed tools to aid in the diagnosis of myopic maculopathy.

Lotfi Merabet, OD, PhD, MPH, discusses his role as co-chairman of a National Eye Institute initiative focused on advancing research in cerebral visual impairment (CVI). The initiative's key goals ...

The award from the National Institutes of Health will enable a team of researchers to investigate Alzheimer and Parkinson ...

In a study, a team of UCLA investigators detail a deep-learning model pre-trained on 2D scans that accurately predicts ...

Jeff Todd, president and CEO of Prevent Blindness, and Donna Fishman, Director of the National Center for Children’s Vision and Eye Health at Prevent Blindness, join David Hutton of Ophthalmology ...

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

Ciclosporin 0.1% eye drops solution will be marketed under the brand name Vevizye in the EU for the treatment of dry eye ...

Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL) , TECNIS Odyssey, in the US.

CVD, an AI diagnostic solution that autonomously assesses future cardiovascular disease risk using a retina scan.